Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
UCB To Buy Ra for $2.1bn And Plays Down Antitrust Fears
Getting hold of zilucoplan, a 'pipeline in a product'
Deal unites two leaders in myasthenia gravis • Source: Shutterstock
More from Deals
More from Business